Use of Contrave, Naltrexone with Bupropion, Bupropion, or Naltrexone and Major Adverse Cardiovascular Events: A Systematic Literature Review

Naltrexone/Bupropion extended release (ER; Contrave) is an extended-release, fixed-dose combination medication of naltrexone (8 mg) and bupropion (90 mg) for patients with obesity or overweight with at least one weight-related comorbidity. Obese and overweight patients with or without comorbidities...

Descripción completa

Detalles Bibliográficos
Autores principales: Dahlberg, Sarah, Chang, Ellen T, Weiss, Sheila R, Dopart, Pamela, Gould, Errol, Ritchey, Mary E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529009/
https://www.ncbi.nlm.nih.gov/pubmed/36200062
http://dx.doi.org/10.2147/DMSO.S381652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529009/
https://www.ncbi.nlm.nih.gov/pubmed/36200062
http://dx.doi.org/10.2147/DMSO.S381652

Ejemplares similares